Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.
Cure My Disease
Don't miss your cure!
Clinical trials sponsored by Genfit, explained in plain language.
This study is testing whether a new drug called GNS561 works better when combined with an existing drug, trametinib, for people with advanced bile duct cancer that has a specific genetic change (KRAS mutation) and has stopped responding to standard chemotherapy. The main goals ar…
Phase: PHASE1, PHASE2 • Sponsor: Genfit • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC